[Trial of device that is not approved or cleared by the U.S. FDA]
Withheld · NCT04189913
At a glance
- Research payments reported, 2025
- $263,895
- U.S. investigators named
- 4
- Sites paid
- 4
About the trial
- Sponsor
- [Redacted]
- Results posted
- Not yet
From ClinicalTrials.gov, last updated 2021-09-16. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Teleflex LLC reported $263,895 in research payments for this study in 2025 (5 payments).
Products named: Barrigel
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Rizwan D. Nurani, MD Radiation Oncology · Apple Valley, CA
- Alexander Engelman, M.D. Radiation Oncology · Tampa, FL
- John L. Lederer, M.D. Radiation Oncology · Honolulu, HI
- Zvi J. Schiffman, MD Urology · Houston, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Interventional Radiation Oncology O $108,500
- Hmu Crc LLC $80,790
- Florida Urology PArtners LLP $56,025
- The Cancer Center of Hawaii LLC $18,580
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.